According to a release, Dr. Fong brings more than 20 years of drug development experience and has led research and development groups in cell and gene therapies, bio-active peptides and recombinant proteins from discovery research to early human clinical trials in oncology and autoimmune and inflammatory diseases.
http://ift.tt/1k4gUIz
http://ift.tt/1k4gUIz
No comments:
Post a Comment